Toxoplasmosis Testing Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Toxoplasmosis Testing Market was worth USD 1.7 billion in 2018 and is expected to grow at a CAGR of 7% from 2022-2028.

Toxoplasmosis is an infection caused by the Toxoplasma gondii parasite. Most cats act as reservoirs for these parasites. According to 2017 disease data from the European Center for Disease Prevention and Control, countries including Poland, the United Kingdom and Germany had a relatively higher number of cases of congenital toxoplasmosis reported in infants, so screening for toxoplasmosis was recommended. precautions must be taken for The disease is transmitted through improperly cooked meat consumption, direct contact with cysts present in cat feces, or through the placenta of a newly infected mother, but in most cases includes mild flu-like illness with no clearly observed symptoms.

Market Segments

By Type
• Testing Equipment
• Reagent Consumables

By Application
• Hospitals
• Commercial Or Private Laboratories
• Physician Offices

Key Players

• Abbott Laboratories
• GenBio
• Beckman Coulter
• Affymetrix
• Biotest
• Bio-Rad Laboratories
• Cepheid
• Biomerica

Scope of the Report

The research study analyzes the global Toxoplasmosis Testing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Toxoplasmosis Testing Market Report

1. What was the Toxoplasmosis Testing Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Toxoplasmosis Testing Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Toxoplasmosis Testing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.